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Background
Hypertrophic cardiomyopathy (HCM) is most common
in patients under 40 years and is associated with early
sudden death, but HCM is increasingly recognized in
elderly patients. We sought to characterize and identify
features unique to elderly HCM patients when com-
pared with youthful patients using CMR.
Methods
Cine CMR and late gadolinium enhancement (LGE) ima-
ging were performed in 902 HCM patients, including 202
young (15-35 years; mean 24.5 ± 6.3 years), and 143
elderly patients (age > 65 years; mean 70.9 ± 4.8 years). ).
Results
Elderly HCM patients had a lower proportion of males
(53.8% elderly vs 70.3%, p=0.002). They had significantly
lower left ventricular (LV) mass (153 ± 64g elderly vs
183 ± 90g, p<0.001) and lower maximal LV wall thick-
ness (19 ± 4mm elderly vs 21±6mm, p<0.001). The
most common maximal thickness segment in the elderly
patients was in the basal anterior septum (35% elderly
vs 22% , p=0.01). Elderly patients were also more likely
to have the thickest segment located within the septum
(OR 1.74, 95% C.I. 1.12 - 2.69, p=0.01). Elderly patients
were far less likely to have massive hypertrophy (maxi-
mal wall thickness >30mm) (OR 0.15, 95% C.I. 0.03-
0.64, p=0.01).
Elderly HCM patients had a smaller LV cavity size,
with lower LV end-diastolic volume (138 ± 41ml elderly
vs 165 ± 45ml, p<0.001) and smaller LV end-diastolic
dimension (52 ± 7mm elderly vs 54 ± 7mm, p=0.05).
The elderly patients had similar LV ejection fraction
(LVEF) (67± 11% elderly vs 66± 9%, p>0.1) and similar
rates of depressed (<60%) LVEF ( 21% elderly vs 20%,
p=0.79).
The prevalence of LGE (a marker of fibrosis) was
similar in both groups (40.9% elderly vs 43.5%, p=0.64).
When present, both LGE mass (8.0 ± 14.7g elderly vs
9.6 ± 15.1g, p>0.10) and percentage of LV with LGE
(8.6 ± 10.4% elderly vs 6.9 ± 8.3%, p>0.10) were similar.
Conclusions
Substantial amounts of late gadolinium enhancement
are compatible with normal longevity in many patients
with hypertrophic cardiomyopathy. Presence of LGE
may thus have different prognostic significance across
the vast spectrum of HCM. This has potential implica-
tions for using LGE as a risk stratification tool for sud-
den death in HCM.
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